Phase 1 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 19 to 65 years old (male or female)
- People who have been diagnosed with type 2 diabetes, with a blood sugar control reading (HbA1c) between 6.5% and 11%, managed through diet alone with no diabetes medications — or people who do not have type 2 diabetes at all (healthy volunteers)
- People who follow regular eating habits that include three meals a day
- People whose blood test results fall within the normal range, as assessed at a screening visit (healthy volunteers must have an HbA1c above 4.0%)
- People who are using a reliable barrier method of contraception, have had a sterilisation procedure, or have been through menopause for at least 2 years
- People who, in the study team's opinion, can understand and follow the visit schedule and study treatment instructions
- People who are able to avoid taking supplements that may affect blood sugar levels for the entire duration of the study (examples include chromium, bitter melon, berberine, cinnamon, ginseng, fenugreek, garlic, and others — confirm full list with trial site)
Who may not be able to join:
- People who are currently in poor health, as assessed by the study doctor
- People who are currently taking any medications, other than vitamins or birth control
- People who do not eat three regular meals a day
- People who have a current or past condition affecting the stomach or intestines, such as inflammatory bowel disease, ulcers in the colon, or a partial blockage in the intestine
- People who have travelled to another country within the four weeks before the study starts
- People who have had surgery within the four weeks before the study starts
- People who are pregnant or currently breastfeeding
- People who plan to take part in another clinical drug trial at the same time as this study
- People with a known allergy to the study medication or any of its ingredients
- People who have a history of not following medical instructions, or who are unwilling or unable to attend all required study visits
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robert Petrella, MD, PhD, University of British Columbia
Phone: 604-875-5886
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximum tolerated dose (MTD)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.